文献速递眼底病与葡萄膜炎

Uvemaster:用于葡萄膜炎鉴别诊断的移动应用决策支持系统

Uvemaster: A Mobile App-Based Decision Support System for the Differential Diagnosis of Uveitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本研究回顾性评估移动应用 Uvemaster 对葡萄膜炎的鉴别诊断准确性与性能,该应用数据库涵盖 88 种葡萄膜炎综合征、76 个临床项目(共 6688 项)。特异性葡萄膜炎病例诊断准确率为 96.6%(95%CI 93.2-100);按敏感度排序时原诊断进入前三为 90.9%、居首为 73.9%。作者结论认为该应用准确,且基于相同临床数据能检出比单纯依赖临床医生更多的特异性葡萄膜炎病例。

要点

  • 特异性葡萄膜炎病例诊断准确率为 96.6%(95%CI 93.2-100)
  • 按敏感度排序,原诊断进入鉴别诊断列表前三为 90.9%,居首为 73.9%
  • 71 例(31.1%)原诊为特发性葡萄膜炎者中作出 19 个新诊断,特发性病例降至 52 例(22.8%)

核心结论

  • 作者认为 Uvemaster 准确,且基于相同临床数据能检出比单纯依赖临床医生方法更多的特异性葡萄膜炎病例。

研究设计与样本

  • 回顾性病例系列研究:在已发表的病例系列中评估诊断准确性(特异性葡萄膜炎 N=88)与诊断性能(特发性葡萄膜炎 N=71),原诊断由葡萄膜炎专科医生作出。
  • Uvemaster 为移动应用(app)即诊断决策支持系统(DDSS),数据库含 88 种葡萄膜炎综合征、各 76 个眼部与全身临床项目(共 6688 项)及其患病率,并按敏感度、特异度或阳性预测值(PPV)排序显示鉴别诊断列表(DDL)。

主要发现

  • 诊断准确率为 96.6%(95%CI 93.2-100)。
  • 按敏感度,原诊断进入 DDL 前三为 90.9%(95%CI 84.1-96.6),居首为 73.9%(95%CI 63.6-83.0)。
  • 按 PPV,原诊断进入 DDL 前三为 62.5%(95%CI 51.1-71.6),居首为 29.5%(95%CI 20.5-38.6;P < 0.001)。
  • 71 例(31.1%)原诊为特发性葡萄膜炎的患者中作出 19 个新诊断,使该系列降至 52 例(22.8%),特异性葡萄膜炎新诊断率提高 8.3%(性能=77.2%;95%CI 71.1-82.9)。

关键数值与推荐

  • 诊断准确性定义:获得正确诊断的病例百分比;诊断性能定义:获得特异性诊断的病例百分比。
  • 按敏感度排序时原诊断居首为 73.9%,按 PPV 排序时居首为 29.5%,两者比较 P < 0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the diagnostic accuracy and performance of Uvemaster, a mobile application (app) or diagnostic decision support system (DDSS) for uveitis. The app contains a large database of knowledge including 88 uveitis syndromes each with 76 clinical items, both ocular and systemic (total 6688) and their respective prevalences, and displays a differential diagnoses list (DDL) ordered by sensitivity, specificity, or positive predictive value (PPV). METHODS: In this retrospective case-series study, diagnostic accuracy (percentage of cases for which a correct diagnosis was obtained) and performance (percentage of cases for which a specific diagnosis was obtained) were determined in reported series of patients originally diagnosed by a uveitis specialist with specific uveitis (N = 88) and idiopathic uveitis (N = 71), respectively. RESULTS: Diagnostic accuracy was 96.6% (95% confidence interval [CI], 93.2-100). By sensitivity, the original diagnosis appeared among the top three in the DDL in 90.9% (95% CI, 84.1-96.6) and was the first in 73.9% (95% CI, 63.6-83.0). By PPV, the original diagnosis was among the top DDL three in 62.5% (95% CI, 51.1-71.6) and the first in 29.5% (95% CI, 20.5-38.6; P < 0.001). In 71 (31.1%) patients originally diagnosed with idiopathic uveitis, 19 new diagnoses were made reducing this series to 52 (22.8%) and improving by 8.3% the new rate of diagnosed specific uveitis cases (performance = 77.2%; 95% CI, 71.1-82.9). CONCLUSIONS: Uvemaster proved accurate and based on the same clinical data was able to detect more cases of specific uveitis than the original clinician only-based method.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Gegundez-Fernandez JA, Fernandez-Vigo JI, Diaz-Valle D, et al. Uvemaster: A Mobile App-Based Decision Support System for the Differential Diagnosis of Uveitis. Invest Ophthalmol Vis Sci. 2017. PMID: 28772309. doi:10.1167/iovs.17-21493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。